Free Trial

CASI Pharmaceuticals (CASI) Institutional Ownership

CASI Pharmaceuticals logo
$0.21 0.00 (0.00%)
As of 05/7/2026

Institutional Ownership Changes (13F Filings) for CASI Pharmaceuticals (NASDAQ:CASI)

Current
Institutional Ownership
Percentage
22.23%
Number of
Institutional Buyers
(last 12 months)
4
Total
Institutional Inflows
(last 12 months)
$918.11K
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$675.24K
Get CASI Insider Trade Alerts

Want to know when executives and insiders are buying or selling CASI Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CASI Institutional Buying and Selling by Quarter

CASI Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Foresite Capital Management VI LLC979,956$1.63M0.6%+24.5%7.968%
11/17/2025Bank of America Corp DE254,884$423K0.0%+2,013.3%2.072%
11/14/2025Two Sigma Investments LP33,267$55K0.0%N/A0.270%
11/5/2025 Wellington Shields Capital Management LLC69,535$115K0.0%-23.5%0.565%
8/12/2025Foresite Capital Management VI LLC787,121$929K0.5%-40.8%6.399%
5/16/2025Woodline Partners LP164,365$355K0.0%+64.9%1.336%
2/17/2025Woodline Partners LP99,690$282K0.0%+226.5%0.644%
2/14/2025Foresite Capital Management VI LLC1,329,383$3.76M1.7%N/A8.582%
2/13/2025ADAR1 Capital Management LLC46,320$131K0.0%-28.6%0.299%
2/10/2025Wellington Shields & Co. LLC30,091$85K0.0%-30.2%0.194%
8/9/2024Renaissance Technologies LLC40,800$224K0.0%+10.9%0.304%
8/5/2024Wellington Shields Capital Management LLC89,217$491K0.1%-3.3%0.666%
5/4/2024Howland Capital Management LLC40,429$146K0.0%N/A0.302%
5/3/2024Wellington Shields Capital Management LLC92,217$333K0.1%-30.7%0.688%
5/11/2023Wellington Shields Capital Management LLC180,143$418K0.1%N/A1.352%
5/11/2023Wellington Shields & Co. LLC139,315$323K0.1%N/A1.046%
11/4/2022Prudential Financial Inc.11,000$29K0.0%N/A0.081%
9/16/2022Federated Hermes Inc.1,015,000$2.90M0.0%-90.0%7.460%
8/15/2022Wellington Shields Capital Management LLC213,250$610K0.1%-90.0%1.567%
8/12/2022Ikarian Capital LLC132,014$378K0.1%-90.0%0.970%
8/12/2022Wellington Shields & Co. LLC145,317$416K0.1%-90.0%1.068%
7/27/2022Bailard Inc.31,530$90K0.0%+25.6%0.232%
5/12/2022Wellington Shields Capital Management LLC2,132,547$1.73M0.2%-2.6%1.561%
5/9/2022Wellington Shields & Co. LLC1,453,190$1.18M0.4%+27.3%1.064%
2/16/2022Wellington Shields & Co. LLC1,141,190$913K0.2%-37.7%0.816%
2/15/2022Wellington Shields Capital Management LLC2,188,547$1.75M0.2%-3.1%1.566%


CASI Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of CASI Pharmaceuticals shares: Foresite Capital Management VI LLC ($1.63M), Bank of America Corp DE ($423K), Woodline Partners LP ($355K), Renaissance Technologies LLC ($224K), ADAR1 Capital Management LLC ($131K), Wellington Shields Capital Management LLC ($115K), and Wellington Shields & Co. LLC ($85K).Learn more on CASI Pharmaceuticals' institutional investors.

22.23% of CASI Pharmaceuticals' stock is owned by institutional investors. Learn more on CASI's institutional investor holdings.

The following institutional investors have purchased CASI Pharmaceuticals' stock in the last 24 months: Foresite Capital Management VI LLC ($1.52M), Bank of America Corp DE ($242.82K), Woodline Partners LP ($133.83K), Two Sigma Investments LP ($33.27K), and Renaissance Technologies LLC ($4K).

Institutional investors have bought a total of 533,600 shares in the last 24 months. This purchase volume represents approximately $918.11K in transactions.

The following institutional investors have sold CASI Pharmaceuticals stock in the last 24 months: Foresite Capital Management VI LLC ($542.26K), and Wellington Shields Capital Management LLC ($21.31K).

Institutional investors have sold a total of 563,572 shares in the last 24 months. This volume of shares sold represents approximately $675.24K in transactions.



This page (NASDAQ:CASI) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners